Today : Mar 22, 2025
Science
22 March 2025

Innovative Imaging Strategy Reveals Long-Term Viral Presence In COVID-19

New research highlights persistent SARS-CoV-2 in lungs and brain three months after infection

In a groundbreaking study, researchers have developed a novel imaging strategy to track the biodistribution of SARS-CoV-2, the virus responsible for COVID-19, in a non-human primate model. This innovative approach, which utilizes a radiolabeled monoclonal antibody, reveals persistent viral presence in various organs, including the lungs and brain, even three months post-infection.

The COVID-19 pandemic has caused over 780 million cases globally, and although the development of treatments and vaccines has significantly reduced mortality, the long-term effects of SARS-CoV-2 infection remain poorly understood. As a result, ongoing research is essential to unravel the complexities surrounding the virus's spread and persistence within the body.

To address these pressing questions, the research team implemented an in vivo imaging technique using the radiolabeled antibody COVA1-27-DFO. This antibody, which specifically targets a preserved epitope of the SARS-CoV-2 spike protein, allows for detailed tracking of the virus by positron emission tomography/computed tomography (PET/CT).

The findings indicate that convalescent non-human primates exhibited a persistent PET signal in their lungs and intriguingly, also in their brains, long after the initial viral infection. This is significant, as it suggests a potential reservoir for the virus that could contribute to long COVID symptoms.

Prior to this method, understanding viral dissemination had been hindered by the limitations of traditional samples obtained from patients, which often do not provide a comprehensive view of the virus's behavior throughout the body. Most research relied on post-mortem examinations or limited sampling, which left many questions unanswered. As stated by the authors of the article, "A complete understanding of the pathogenesis of COVID-19 still requires new approaches that allow extensive characterization of viral dissemination, persistence, and reservoirs at the whole-body scale."

The study utilized cynomolgus macaques, a non-human primate model that closely resembles human physiology, making it particularly relevant for investigating SARS-CoV-2 infection dynamics. The researchers conducted their experiments under strict BSL-2 and BSL-3 containment protocols to ensure the safety of both the animals and the researchers involved.

Using the [89Zr]COVA1-27-DFO PET imaging technique, the team was able to observe the dynamics of SARS-CoV-2 dissemination during acute infection phases, with a focus on both the critical upper and lower respiratory tracts where the virus typically appears. They found that the imaging system could detect viral signals across multiple organs, including the nasal cavity and kidneys.

Perhaps most crucially, the results showed that there was a significant accumulation of the radiotracer in the lungs and in brain tissues of convalescent animals, indicating that the virus could persist in these critical areas long after the primary infection. The authors note, "This approach provides a powerful innovative tool to study COVID-19 pathophysiology and viral spreading."

This research advances our understanding of long COVID by offering a non-invasive method for tracking the virus and potentially identifying regions where it can linger in the body. Future studies using this imaging approach could help explore further questions regarding chronic inflammation and other symptoms associated with long COVID.

The implications of this study are significant, not only for understanding the biology of SARS-CoV-2 but also for informing treatment and vaccine strategies. By elucidating how the virus operates at a systemic level, researchers can better investigate long-term effects and develop more effective therapeutic interventions.

The research team emphasizes that ongoing efforts are needed to monitor the evolving nature of the virus and its variants. With COVID-19 continuing to affect populations worldwide, this innovative imaging technology may prove essential in addressing the challenges posed by SARS-CoV-2 and its long-lasting impacts on human health.